Production of atypical measles in rhesus macaques: Evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion-inhibiting antibody

Nature Medicine

Volumn 5, Issue 6, 1999, Pages 629-634

  Polack, Fernando P ^a,b   Auwaerter, Paul G ^b   Lee, Sok H ^a   Nousari, Hossein C ^b   Valsamakis, Alexandra ^a,b   Leiferman, Kristin M ^c   Diwan, Arwind ^d   Adams, Robert J ^b   Griffin, Diane E ^a,b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MAYO CLINIC   (United States)

^d UNIVERSITY OF HAWAII   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FORMALDEHYDE; HYBRID PROTEIN; INACTIVATED VACCINE; LOT 354034; MEASLES VACCINE; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; CELL LINE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DISEASE SEVERITY; EOSINOPHIL; FEMALE; IMMUNE COMPLEX DEPOSITION; IMMUNIZATION; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MEASLES; MEASLES VIRUS; MONKEY; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL; RASH; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; ANTIBODIES, VIRAL; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; EOSINOPHILIA; EOSINOPHILS; FEMALE; IMMUNOGLOBULIN A; MACACA MULATTA; MALE; MEASLES; MEASLES VACCINE; SKIN; VACCINES, INACTIVATED;

ANIMALIA; MACACA MULATTA; MEASLES VIRUS;

EID: 0033031217     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/9473     Document Type: Article

References (41)

1. Albrecht, P., Ennis, F.A., Saltzman, E.J. & Krugman, S. Persistence of maternal antibody in infants beyond 12 months: Mechanism of measles vaccine failure J.Pediatr. 91, 715-178 (1977).
2. Gans, H.A. et al. Deficiency of the humoral immune response to measles vaccine in infants immunized at age 6 months. J. Am. Med. Assoc. 280, 527-532 (1998).
3. Holt, E.A., Moulton, L.H., Siberry, G.K. & Halsey, N.A. Differential mortality by measles vaccine titer and sex. J. Infect. Dis. 168, 1087-1096 (1993).
4. Berry, S. et al. Comparison of high titer Edmonston-Zagreb, Biken-CAM and Schwarz measles vaccines in Peruvian infants. Pediatr. Infect. Dis. J. 11, 822-827 (1992).
5. Garenne, M., Leroy, O., Beau, J.-P. & Sene, I. Child mortality after high-litre measles vaccines: prospective study in Senegal. Lancet 338, 903-907 (1991).
6. Carter, C.H. et al. Serologic response of children to inactivated measles vaccine. J. Am. Med. Assoc. 179, 848-853 (1962).
7. Guinee, V.F., Henderson, D.A., Casey, H.L., et al. Cooperative measles vaccine field trial I. Clinical efficacy. Pediatrics 37, 649-657 (1966).
8. Fulginiti, V.A., Eller, J.I., Downie, A.W. & Kempe, C.H. Altered reactivity to measles virus: Atypical measles in children previously immunized with inactivated measles virus vaccines. J. Am. Med. Assoc. 202, 1075 (1967).
9. Martin, D.B., Weiner, L.B., Nieburg, P.I. & Blair, D.C. Atypical measles in adolescents and young adults. Ann. Int. Med. 90, 877-881 (1979).
10. Young, L.W., Smith, D.I. & Glasgow, L.A. Pneumonia of atypical measles. Residual nodular lesions. Am. J. Roentgenol. 110, 439-448 (1970).
11. Rauh, L.W. & Schmidt, R. Measles immunization with killed virus vaccine. Am. J. Dis. Child. 109, 232-237 (1965).
12. Nader, P.R., Horwitz, M.S. & Rousseau, J. Atypical exanthem following exposure to natural measles: Eleven cases in children previously inoculated with killed vaccine. J. Pediatr. 72, 22-28 (1968).
13. McLean, D.M. et al. Atypical measles following immunization with killed measles vaccine Cand. Med. Assoc. J. 103, 743-744 (1970).
14. Centers for Disease Control. Atypical measles - California, 1974-1975. Morb. Mort. Weekly. Rep. 25, 245-246 (1976).
15. Buser, F. Side reaction to measles vaccination suggesting the Arthus phenomenon. N. Engl. J. Med. 277, 250-251 (1967).
16. Lennon, R.G. et al. Skin test with measles and poliomyelitis vaccines in recipients of inactivated measles virus vaccine. J. Am. Med. Assoc. 200, 99-104 (1967).
17. Fulginiti, V.A., Arthur, J.H., Pearlman, D.S. & Kempe, C.H. Altered reactivity to measles virus:Local reactions following attenuated measles virus immunization in children who previously received a combination of inactivated and attenuated vaccines. Am. J. Dis. Child. 115, 67-72 (1968).
18. Scott, T.F.M. & Bonanno, D.E. Reactions to live-measles-virus vaccine in children previously inoculated with killed-virus vaccine. N. Engl. J. Med. 277, 248-250 (1967).
19. Krause, P.J., Cherry, J.D., Naiditch, M.J., Deseda-Tous, J. & Walbergh, E.J. Revaccination of previous recipients of killed measles vaccine: Clinical and immunologic studies. J. Pediatr. 93, 565-571 (1978).
20. Fulginiti, V.A. & Arthur, J.H. Altered reactivity to measles virus. J. Pediatr. 75, 609-616 (1969).
21. Norrby, E., Enders-Ruckle, G. & ter Meulen, V. Difference in the appearance of antibodies to structural components of measles virus after immunization with inactivated and live virus. J. Infect. Dis. 132, 262-269 (1975).
22. Norrby, E. & Gollmar, Y. Identification of measles virus-specific hemolysis-inhibiting antibodies separate from hemagglutination-inhibiting antibodies. Infect. Immun. 11, 231-239 (1975).
23. Merz, D.C., Scheid, A. & Choppin, P.W. Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. J. Exp. Med. 151, 275-288 (1980).
24. Kim, H.W. et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am. J. Epidemiol. 89, 422-434 (1968).
25. Fulginiti, V.A. et al. Respiratory virus immunization I. A field trial of two inactivated respiratory virus vaccines; an aqueous trivalent parainfluenza virus vaccine and an alum-precipitated respiratory syncytial virus vaccine. Am. J. Epidemiol. 89, 435-447 (1968).
26. Connors, M. et al. Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of CD4+ T cells. J. Virol. 66, 7444-7451 (1992).
27. Waris, M., Ziegler, T., Kivivirta, M. & Ruuskanen, O. Rapid detection of respiratory syncytial virus and influenza A virus in cell cultures by immunoperoxidase staining with monoclonal antibodies. J. Clin. Microbiol. 28, 1159-1162 (1990).
28. Auwaerter, P.G. et al. Measles virus infection in rhesus macaques: Altered immune responses and comparison of the virulence of six different virus strains. J. Infect. Dis. (in the press).
29. Wild, T.F., Malvoisin, E. & Buckland, R. Measles virus: both the haemagglutinin and fusion glycoproteins are required for fusion. J. Gen. Virol. 72, 439-442 (1991).
30. Cardoso, A.I., Beauverger, P., Gerlier, D., Wild, T.F. & Rabourdin-Combe, C. Formaldehyde inactivation of measles virus abolishes CD46-dependent presentation of nucleoprotein to murine class I-restricted CTLs but not to class II-restricted helper T cells. Virology 212, 255-258 (1995).
31. Norrby, E., Lagercrantz, R. & Gard, S. Measles Vaccination VI. Serological and clincal follow-up analysis 18 months after a booster injection. Acta Paediatr. Scand. 55, 457-462 (1966).
32. Hankins, R.W. & Black, F.L. Western blot analyses of measles virus antibody in normal persons and in patients with multiple sclerosis, subacute sclerosing panencephalitis, or atypical measles. J. Clin. Microbiol. 24, 324-329 (1986).
33. Warren, J., Kammer, H. & Gallian, M.J. Immunization of monkeys with an inactivated measles antigen and their response to a subsequent measles infection. Arch. ges Virusforsch 11, 748-753 (1962).
34. Lentsch, A.B., Czermak, B.J., Bless, N.M. & Ward, P.A. NF-KappaB activation during IgG immune complex-induced lung injury: requirements for TNF-alpha and IL-1beta but not complement. Am. J. Pathol. 152, 1327-1331 (1998).
35. Warren, J.S., Yabroff, K.R., Remick, D.G., et al. Tumor necrosis factor participates in the pathogenesis of acute immune complex alveolitis in the rat. J. Clin. Invest. 84, 1873-1882 (1989).
36. Warren, J.S., Barton, P.A. & Jones, M.L. Contrasting roles for tumor necrosis factor in the pathogenesis of IgA and IgG immune complex lung injury. Am. J. Pathol. 138, 581-590 (1991).
37. Hall, W.J. & Hall, C.B. Atypical measles in adolescents: Evaluation of clinical and pulmonary function. Ann. Intern. Med. 90, 882-886 (1979).
38. Annunziato, D. et al. Atypical measles syndrome: Pathologic and serologic findings. Pediatrics 70, 203-209 (1982).
39. Bellanti, J.A. Biologic significance of the secretory γA immunoglobulins. Pediatrics 48, 715-729 (1971).
40. Bellanti, J.A., Sanga, R.L., Klutinis, B., Brandt, B. & Artenstein, M.S. Antibody responses in serum and nasal secretions of children immunized with inactivated and attenuated measles-virus vaccines. N. Engl. J. Med. 280, 628-633 (1969).
41. Beauverger, P., Buckland, R. & Wild, F. Establishment and characterisation of murine cells constitutively expressing the fusion, nucleoprotein and matrix proteins of measles virus. J. Virol. Meth. 44, 199-210 (1993).